Wikipedia -WSS

Wikipedia

author：explore 2025-08-12 09:11:25 - browse：13247

A dosage of Wegovy, a drug used for weight loss — Amanda Andrade-Rhoades/AP

U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment.

The new label indicates that Wegovy can be used to reduce the risk of major heart complications — including heart attack, stroke, or cardiovascular-related deaths — for people with overweight or obesity and existing heart disease, Novo said in a statement Friday.

The decision was based on results of a large, five-year trial that showed Wegovy cut the risk of cardiovascular problems by 20% in that population. This is the first time a weight loss treatment has been approved to also help improve heart outcomes, the FDA said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Industry veterans launch new biotech VC with $310M

focus

WSS

What we’ve learned from the Aduhelm mess

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Global cancer cases to surge 77% by 2050, WHO report says

Readout LOUD: Venture capital, Gilead, and more M&A

Industry veterans launch new biotech VC with $310M

explore

Wikipedia

focus

In Memoriam: Notable people who died in 2023

Biden report: The neurospychology of memory and aging

DIEP, the 'gold standard' of breast reconstruction, is under threat

A single Democrat is willing to weaken Medicare negotiation power

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Surgery pushed Ben Carson to fame

23andMe had bad news about my health. I wish a person had delivered it

Robert F. Kennedy is pitching centrism on health, even on abortion

23andMe had bad news about my health. I wish a person had delivered it

Readout LOUD: Venture capital, Gilead, and more M&A

Wikipedia

Gilead might be held responsible for not developing a drug

Vaccine advisory panel ACIP left half staffed by HHS

A protest over insulin prices is seen as a fight for life

340B reform proposal comes out of Senate working group

Gene therapy for Afghan refugees’ infant will be fully covered

Biogen Alzheimer’s drug launch off to slow start

hotspot

explore

focus

Wikipedia